Literature DB >> 22215554

Analysis of common mitochondrial DNA mutations by allele-specific oligonucleotide and Southern blot hybridization.

Sha Tang1, Michelle C Halberg, Kristen C Floyd, Jing Wang.   

Abstract

Mitochondrial disorders are clinically and genetically heterogeneous. There are a set of recurrent point mutations in the mitochondrial DNA (mtDNA) that are responsible for common mitochondrial diseases, including MELAS (mitochondrial encephalopathy, lactic acidosis, stroke-like episodes), MERRF (myoclonic epilepsy and ragged red fibers), LHON (Leber's hereditary optic neuropathy), NARP (neuropathy, ataxia, retinitis pigmentosa), and Leigh syndrome. Most of the pathogenic mtDNA point mutations are present in the heteroplasmic state, meaning that the wild-type and mutant-containing mtDNA molecules are coexisting. Clinical heterogeneity may be due to the degree of mutant load (heteroplasmy) and distribution of heteroplasmic mutations in affected tissues. Additionally, Kearns-Sayre syndrome and Pearson syndrome are caused by large mtDNA deletions. In this chapter, we describe a multiplex PCR/allele-specific oligonucleotide (ASO) hybridization method for the screening of 13 common point mutations. This method allows the detection of low percentage of mutant heteroplasmy. In addition, a nonradioactive Southern blot hybridization protocol for the analysis of mtDNA large deletions is also described.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22215554     DOI: 10.1007/978-1-61779-504-6_18

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

Review 1.  Challenges of bringing next generation sequencing technologies to clinical molecular diagnostic laboratories.

Authors:  Lee-Jun C Wong
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

2.  Advanced approach for comprehensive mtDNA genome testing in mitochondrial disease.

Authors:  Jing Wang; Jorune Balciuniene; Maria Alejandra Diaz-Miranda; Elizabeth M McCormick; Erfan Aref-Eshghi; Alison M Muir; Kajia Cao; Juliana Troiani; Alicia Moseley; Zhiqian Fan; Zarazuela Zolkipli-Cunningham; Amy Goldstein; Rebecca D Ganetzky; Colleen C Muraresku; James T Peterson; Nancy B Spinner; Douglas C Wallace; Matthew C Dulik; Marni J Falk
Journal:  Mol Genet Metab       Date:  2021-12-18       Impact factor: 4.204

3.  Homoplasmy of the m. 8993 T>G variant in a patient without MRI findings of Leigh syndrome, ataxia or retinal abnormalities.

Authors:  Russell P Saneto; Kristina E Patrick; Francisco A Perez
Journal:  Mitochondrion       Date:  2021-04-22       Impact factor: 4.534

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.